fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element - PubMed (original) (raw)

fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element

K McBride et al. Mol Cell Biol. 1993 Jan.

Abstract

Unlike that of skeletal muscle cells in which growth and differentiation appear mutually exclusive, growth stimulation of cardiac cells is characterized by transient expression of early response nuclear proto-oncogenes as well as induction of several cardiac-specific markers. This observation led to the speculation that these proto-oncogenes, particularly c-fos and c-jun, might act as positive regulators of cardiac transcription. We have examined the role of c-jun and c-fos in basal and growth-stimulated cardiac transcription, using the cardiac-specific atrial natriuretic factor (ANF) gene as a marker. The results indicate that c-jun and c-fos are negative regulators of ANF transcription. Inducers of jun and fos activity, such as mitogens and growth factors, inhibited endogenous ANF transcripts. In transient cotransfection assays, jun and fos were able to trans-repress the ANF promoter in both quiescent and alpha 1-adrenergic stimulated myocytes. This repression was specific to myocyte cultures and was not observed in nonmuscle cells. Deletion analysis indicated that repression does not require typical AP-1-binding sites (tetradecanoyl phorbol acetate response elements) or serum response elements but is targeted at a cardiac-specific element within the ANF promoter. Various Fos-related proteins, including Fra-1, Fos B, and v-Fos, were able to trans-repress ANF transcription. In addition, C-terminal c-fos mutants which no longer repress transcription of such early growth response genes as c-fos and EGR-1 retained the ability to repress ANF transcription. Repression by c-jun occurs via the N-terminal activation domain and does not require the DNA-binding domain, suggesting that proto-oncogene repression involves interaction with one or more limiting cardiac-specific coactivators.

PubMed Disclaimer

Similar articles

• The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.
  McBride K, Nemer M. McBride K, et al. Mol Cell Biol. 1998 Sep;18(9):5073-81. doi: 10.1128/MCB.18.9.5073. Mol Cell Biol. 1998. PMID: 9710591 Free PMC article.
• Collaborative roles for c-Jun N-terminal kinase, c-Jun, serum response factor, and Sp1 in calcium-regulated myocardial gene expression.
  McDonough PM, Hanford DS, Sprenkle AB, Mellon NR, Glembotski CC. McDonough PM, et al. J Biol Chem. 1997 Sep 19;272(38):24046-53. doi: 10.1074/jbc.272.38.24046. J Biol Chem. 1997. PMID: 9295358
• Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1.
  Bruneau BG, de Bold AJ. Bruneau BG, et al. Cardiovasc Res. 1994 Oct;28(10):1519-25. doi: 10.1093/cvr/28.10.1519. Cardiovasc Res. 1994. PMID: 8001040
• Encounters with Fos and Jun on the road to AP-1.
  Abate C, Curran T. Abate C, et al. Semin Cancer Biol. 1990 Feb;1(1):19-26. Semin Cancer Biol. 1990. PMID: 2133107 Review.
• Growth factors, growth factor response elements, and the cardiac phenotype.
  Schneider MD, McLellan WR, Black FM, Parker TG. Schneider MD, et al. Basic Res Cardiol. 1992;87 Suppl 2:33-48. doi: 10.1007/978-3-642-72477-0_4. Basic Res Cardiol. 1992. PMID: 1284369 Review.

Cited by

• Modulation of MLC-2v gene expression by AP-1: complex regulatory role of Jun in cardiac myocytes.
  Goswami SK, Shafiq S, Siddiqui MA. Goswami SK, et al. Mol Cell Biochem. 2001 Jan;217(1-2):13-20. doi: 10.1023/a:1007296330181. Mol Cell Biochem. 2001. PMID: 11269656
• The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium.
  Durocher D, Chen CY, Ardati A, Schwartz RJ, Nemer M. Durocher D, et al. Mol Cell Biol. 1996 Sep;16(9):4648-55. doi: 10.1128/MCB.16.9.4648. Mol Cell Biol. 1996. PMID: 8756621 Free PMC article.
• CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapy.
  Jia Z, Jia J, Zhang S, Cao J. Jia Z, et al. Cancer Gene Ther. 2020 May;27(5):389-392. doi: 10.1038/s41417-019-0106-x. Epub 2019 May 27. Cancer Gene Ther. 2020. PMID: 31130730 No abstract available.
• Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload.
  Herzig TC, Jobe SM, Aoki H, Molkentin JD, Cowley AW Jr, Izumo S, Markham BE. Herzig TC, et al. Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7543-8. doi: 10.1073/pnas.94.14.7543. Proc Natl Acad Sci U S A. 1997. PMID: 9207128 Free PMC article.
• Notch signaling mediates between two pattern-forming processes during head regeneration in Hydra.
  Steichele M, Sauermann L, Pan Q, Moneer J, de la Porte A, Heß M, Mercker M, Strube C, Flaswinkel H, Jenewein M, Böttger A. Steichele M, et al. Life Sci Alliance. 2024 Nov 12;8(1):e202403054. doi: 10.26508/lsa.202403054. Print 2025 Jan. Life Sci Alliance. 2024. PMID: 39532539 Free PMC article.

References

1. 1. EMBO J. 1990 Sep;9(9):2827-34 - PubMed
2. 1. Cell. 1990 Sep 21;62(6):1205-15 - PubMed
3. 1. Cell. 1990 Sep 21;62(6):1217-26 - PubMed
4. 1. J Biol Chem. 1991 Jul 15;266(20):12813-6 - PubMed
5. 1. Am J Physiol. 1991 Nov;261(5 Pt 2):H1443-51 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal